MARYANN HALL: Open Payments
NPI 1245238518 · LACKEY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 32 payments from 9 companies in 2025. Trend: 2023 $442 · 2024 $1,493 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $212 |
| AstraZeneca Pharmaceuticals LP | 4 | $108 |
| PFIZER INC. | 5 | $85 |
| Novo Nordisk Inc | 2 | $41 |
| Lundbeck LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: FARXIGA, QULIPTA, VRAYLAR, NURTEC ODT, REXULTI, Auvelity, Ozempic, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
